The U.S. government this week released the list of the 10 medications that will be the first to be the subject of the new price negotiations under the Medicare reform bill, and my arthritis drug, Enbrel, made the list. To make the cut, you either had to be taken by millions of people, like Eliquis, or cost a fortune. Enbrel costs a fortune. I’m one of 47,000 Medicare recipients lucky enough to…